Dr. Florian Vogel

Angestellt, National Business Leader Clinical Genetics Services Germany, Eurofins Scientific Group

Abschluss: eMBA with Honors, Quantic School of Buisness and Technology

Planegg, Deutschland

Fähigkeiten und Kenntnisse

Human Genetics
Rare Disease Genetics
Molecular Genetics
corona virus testing
COVID 19
Next Generation Sequencing
Diagnostic
Genotyping
molecular biology
biochemistry
biotechnology
Quality Management
Qualitätskontrolle
new technologies
bioanalytics
viral vectors
insect cell expression
virology
plant genetics

Werdegang

Berufserfahrung von Florian Vogel

  • Bis heute 1 Jahr und 4 Monate, seit März 2023

    National Business Leader Clinical Genetics Services Germany

    Eurofins Scientific Group

    OBP Leader Clinical Genetics Services Europe Managing Director at Eurofins Humangenetik und Pränatal-Medizin MVZ GmbH Managing Director at Eurofins Lifecodexx GmbH

  • 2 Jahre und 2 Monate, Jan. 2021 - Feb. 2023

    Chief Process Officer

    Centogene GmbH

    - Responsibility for Operations (rare disease diagnostic Lab Operations in Rostock (Germany) and Cambridge (USA)) - Managing Director at German legal entity (GmbH) since 06/2021

  • 1 Jahr und 9 Monate, Apr. 2019 - Dez. 2020

    Senior Vice President Clinical Lab Operations

    Centogene AG

    - Disciplinary & budget responsibility for complete chain of molecular diagnostic and Pharma-Partner-related sample receipt, customer interaction, processing and medical reporting (including 10 departments) as well as Method & Process Development and Production Controlling in Centogene AG Rostock, reporting to CEO - Setup and lead of the SARS-CoV-2 (COVID 19) testing department in Centogene Rostock - Disciplinary & budget responsibility for CLIA & CAP lab processing facility in Cambridge, MA

  • 10 Monate, Juni 2018 - März 2019

    Vice President NGS Processing and Method Development

    Centogene AG

    - Disciplinary & budget responsibility for diagnostic NGS Processing department and the Method and process development department, reporting to COO - Disciplinary & budget responsibility for CLIA & CAP lab processing facility in Cambridge, MA (Centogene US LLC); responsible for planning and setup of Centogene US LLC operations and there after production since start at October 1st 2018

  • 8 Monate, Okt. 2017 - Mai 2018

    Senior Director Research & Development

    Centogene AG

    - Team of 12 FTE, disciplinary & budget responsibility for R&D dept., reporting to CSO - Product development for diagnostic methods in rare diseases or cancer, implementation in internal workflows & market release - Optimization of genetic portfolio (>210 NGS panels, high-throughput single gene testing, WES, WGS, ddPCR, somatic assays) regarding COGS, market positioning and quality - Validation & documentation of assays acc. to current regulatory standards, especially for submission to FDA

  • 1 Jahr und 2 Monate, Aug. 2016 - Sep. 2017

    Director Research & Development

    Centogene AG

  • 1 Jahr, Aug. 2015 - Juli 2016

    Vice Director New Technologies

    Centogene AG

  • 2 Jahre und 6 Monate, Okt. 2012 - März 2015

    Director of Genetics Division and Quality Control

    EuroFerm GmbH

    Adenoviral Vector Production and Baculovirus Biopesticide Development. Establishment of molecular Quality Control tools for virus and cell lines. Executive coordinator for R&D, purification and characterization of novel virus isolates. Application and guidance of biosafety level II workspace.

  • 2 Jahre, Sep. 2010 - Aug. 2012

    Laboratory Head and Acting Head of Department

    FAU Campus Busan

    Acting Chief of Environmental Process Engineering / White Biotechnology Department and Lecturer on the branch campus in Korea. Set up of a German branch university in the Republic of Korea: Implementation of research and teaching, build up and outfitting of laboratories, student recruitment. Development of an inducible toxin-enhanced baculovirus-based bio pesticide.

  • 1 Jahr und 1 Monat, Aug. 2009 - Aug. 2010

    Postdoctoral Research Associate

    Friedrich-Alexander Universität Erlangen-Nürnberg; Biochemistry division

    Primary research scientist working on molecular cell-to-cell trafficking and virus-host interactions. Establishment of research and respective techniques in the field of sRNA at the department. Development and supervision of an independent research project in this field for a masters student. Supervision and project development together with my supervisor for a doctoral researcher.

  • 4 Jahre, Aug. 2005 - Juli 2009

    Doctoral Researcher

    Friedrich-Alexander Universität Erlangen-Nürnberg

    Primary research scientist investigating molecular cell-to-cell trafficking/communication and virus-host interactions by studying poleroviral movement protein MP17 in Arabidopsis thaliana and tobacco. Main focus on reverse genetics (molecular mapping), laser confocal microscopy, cell biology, in planta protein expression and purification. Independent project planning and supervision of four diploma / masters students and several undergraduate students in the lab.

Ausbildung von Florian Vogel

  • 1 Jahr und 2 Monate, Okt. 2021 - Nov. 2022

    Executive Master of Business Administration

    Quantic School of Buisness and Technology

  • 4 Jahre, Aug. 2005 - Juli 2009

    Doctoral Thesis

    Friedrich-Alexander Universität Erlangen-Nürnberg

    Virus-host interactions; Cell-cell communication; Plant molecular physiology; Harvest index modification & Molecular plant engineering Plant/virus genetics; Protein expression/purification; DNA/RNA/sRNA techniques

  • 4 Jahre und 8 Monate, Okt. 2000 - Mai 2005

    Diploma in Biology

    Friedrich-Alexander Universität Erlangen-Nürnberg

    Molecular Plant Physiology (thesis about plant molecular cell-to-cell trafficking and communication); Virology; Biochemistry; Medical Microbiology

Sprachen

  • Englisch

    Fließend

  • Koreanisch

    Grundlagen

  • Deutsch

    Muttersprache

Interessen

quality management
molecular science
life science
white biotechnology
Vaccine Development
Human genetics
Rare Disease Genetics

21 Mio. XING Mitglieder, von A bis Z